Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 21 hours agoLast year, sales tumbled 42% to nearly $58.5 billion. Top sellers included Comirnaty and Paxlovid,...
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 19 hours agoThe result is that Pfizer is quickly developing newer products that will eventually replace not just...
To Your Good Health: Purpura spots appear as skin begins to get thinner
The Marshall News Messenger· 2 days agoIn 2022, I had the WATCHMAN procedure. Prior to the WATCHMAN implant, I took Eliquis to help prevent...
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
Motley Fool via Yahoo Finance· 5 days agoBoth offer above-average yields now, and they're well positioned to grow their dividend payouts....
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 18 hours agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Millions of Americans need drugs like Ozempic. Will it bankrupt the health care system?
The Columbian· 6 days agoAn April 24 letter from Vermont Sen. Bernie Sanders to the CEO of Novo Nordisk began with heartfelt...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 3 days agoHowever, that will be partly offset by losses in revenue totaling between $16 billion and $18...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo Finance· 3 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Finance· 3 days agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co...
My 3 Top Stocks to Buy in June
247wallst.com· 3 days ago24/7 Insights Sell in May and go away? Maybe not this year, but be careful. Altria Group Inc. (NYSE MO) still owns 8% of Anheuser-Busch InBev S.A. (NYSE:...